T. Bouillon et al., CONCENTRATION-EFFECT RELATIONSHIP OF THE POSITIVE CHRONOTROPIC AND HYPOKALEMIC EFFECTS OF FENOTEROL IN HEALTHY WOMEN OF CHILDBEARING AGE, European Journal of Clinical Pharmacology, 51(2), 1996, pp. 153-160
Objective. To analyse fenoterol-induced tachycardia and hypokalaemia,
the most important and most frequent adverse effects of tocolytic ther
apy with beta(2)-adrenoceptor agonists in females of childbearing age.
Methods: The study was performed as a double blind, randomised, place
bo controlled, cross over trial. Seven healthy women aged 22-38 y, rec
eived intravenous infusions of fenoterol at 3 different rates within t
he therapeutic range for tocolysis (0.5, 1.0, and 2.0 mu g . min(-1))
and placebo. The time courses of the plasma concentrations of fenotero
l and potassium, and the heart rate were analysed with mixed effects p
harmacokinetic-pharmacodynamic (PKPD) modeling using NONMEM. Results:
The plasma concentration-time course followed a linear two compartment
model. Fenoterol-induced tachycardia was described by a linear concen
tration-effect model with baseline. The estimated baseline and slope p
arameters were 78 beats . min(-1) and 0.032 beats . min(-1).mu g(-1).
1, respectively. Fenoterol-induced hypokalaemia could be described by
a physiological indirect response model including feedback; the Estima
ted basal plasma potassium concentration was 3.93 mmol . l(-1) and the
slope factor for the fenoterol-induced relative increase in the efflu
x of potassium from the extracellular space was 6.2210(-4) ng . l(-1)
. Conclusion: The estimated population parameters permitted calculatio
n of the expected time course of tachycardia and hypokalaemia in women
after the initiation of tocolysis with fenoterol over the clinically
relevant concentration range, and prediction of its variability. Based
on simulation, our model predicted that a continous infusion of 2.0 m
u g . min(-1) (highest rate examined) would increase heart rate to 113
beats . min(-1) at steady state and lower the plasma potassium concen
tration to 2.77 mmol . l(-1) 1.5 h after beginning the infusion. There
after, the plasma potassium concentration would slowly return to norma
l.